Flu Vaccine Market is estimated to be US$ 8179.4 million by 2030 with a CAGR of 8.1% during the forecast period
The Flu Vaccine Market accounted for US$
4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is
anticipated to register a CAGR of 6.0%. Influenza virus is continuously
circulating causing regional epidemics and outbreaks, leading to thousands of
deaths. For instance, according to Centers for Disease Control and Prevention
(CDC) more than 13 million flu cases are recorded so far in the time-frame of
2019-20. World Health Organization (WHO) recommended numerous licensed seasonal
influenza vaccines. The rising demand for vaccine is anticipated to surge the
global influenza vaccine market.
Key Highlights:
·
In 2020,
Abbott launched a new inactivated quadrivalent vaccine for influenza, first of
its kind sub-unit vaccine offering protection against this strains in India.
Approved vaccine is for below 3 years.
·
In August
2020, AstraZeneca increases its manufacturing effects to deliver more FluMIST by
collaborating with top key players such as GlaxoSmithKline, Sanofi, Seqirus in
efforts to increase the manufacturing of vaccine
Analyst View:
Increasing investment and the growing government
funding have boosted research and development of pharmaceutical companies which
drives the market. Growing demand for pediatric vaccine as highest market size
is covered among the age group. Quadrivalent vaccines are in great demands as
they protect from four strains of the influenza virus through a single vaccine
which boost the market of flu vaccine.
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230
The Global Flu Vaccine Market accounted for US$
4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is
anticipated to register a CAGR of 6.0%. The Global Flu Vaccine Market is
segmented based on the type,
application and region.
·
By Type, the
Global Flu Vaccine Market is segmented into Split Virus Vaccines, Subunit
Vaccines, and Others
·
By
Application, the market is segmented in For Children and For Adults and
Children over 3 years
·
By region, the
Global Flu Vaccine Market is segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa.
The key players operating in the Global Flu
Vaccine Market include CSL Itd, GSK LLc, Sanofi Pasteur, Mylan N.V.,
AstraZeneca PLC, Pfizer Inc., and Johnson & Johnson Company.
The market provides detailed information
regarding the industrial base, productivity, strengths, manufacturers, and
recent trends which will help companies enlarge the businesses and promote
financial growth. Furthermore, the report exhibits dynamic factors including
segments, sub-segments, regional marketplaces, competition, dominant key
players, and market forecasts. In addition, the market includes recent
collaborations, mergers, acquisitions, and partnerships along with regulatory
frameworks across different regions impacting the market trajectory. Recent
technological advances and innovations influencing the global market are
included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research,
analytics, marketing/business strategy, and solutions that offers strategic and
tactical support to clients for making well-informed business decisions and to
identify and achieve high-value opportunities in the target business area. We
also help our clients to address business challenges and provide the best
possible solutions to overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com

Comments
Post a Comment